Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Opioid-free Total Hip Arthroplasty: A Randomized Controlled Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04421196

Organisation Name: Johns Hopkins University

Overal Status: Not yet recruiting

Start Date: January 1, 2021

Last Update: August 27, 2020

Lead Sponsor: Johns Hopkins University

Brief Summary: The primary objective of investigators' proposed study is to demonstrate that the following two cohorts undergoing total hip arthroplasty will have equivalent visual analog scale (VAS) scores up to 3 months post-operatively: one that is administered a modified multimodal analgesic pathway without opioids and the other administered the current standard multimodal analgesic pathway used at Johns Hopkins Bayview Hospital (which includes opioids). The secondary objective is to demonstrate that these cohorts will also have equivalent functional outcomes as determined by both objective measures (such as hip range of motion) and patient-reported outcome measures, such as the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the University of California at Los Angeles (UCLA) activity score.

Conditions:
  • Hip Osteoarthritis


Total execution time in seconds: 0.20230197906494